Development of novel technologies and targeted therapies for advanced healthcare solutions.
a. Anticancer therapeutics
Research activities are focussed on a greater understanding of the molecular interactions and development of unique genetic therapies that can be applied for the detection and treatment of highly aggressive metastatic disease.
b. Nano-delivery of macromolecules
Research activities are focussed on the design and synthesis of nanotechnologies as local and systemic delivery systems for DNA, RNAi, miRNA, and Au nanoparticle therapies.
c. Proteases in Disease
Research activities are focussed on the development of novel strategies for the detection, characterisation and inhibition of proteases implicated in chronic diseases including respiratory, cardiovascular, cancer and infection with an emphasis on ion channel modulation, inflammatory microenvironments and immune signalling.
d. Natural Peptides
Research activities are focussed on the isolation and characterisation of bioactive peptides derived from animal venoms in order to discover novel antimicrobial, anticancer, antidiabetic, antihypertensive and immunostimulating therapeutic agents.